Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

NCCI Reports on Medicare Fee Schedule Impact on Workers’ Comp

The report focuses on changes made to the Physician Fee Schedule, for Facility Payment Systems, and for the DMEPOS Fee Schedule.
Read More →
August 24, 2026

Tennessee to Require AI Disclosure in Litigation Filings

Any litigant, party, or attorney who files any pleading, motion, brief, or other document to the Board, must include a disclosure statement.
Read More →
August 17, 2026

VA Launches Psilocybin Trial for Veterans with Treatment-Resistant Depression

In addition to this trial, VA is involved in 20 active clinical trials focused on psychedelic therapies for mental health conditions.
Read More →
August 17, 2026

Illinois Enacts New UR and IME Requirements

Employers, payers, and utilization review organizations must comply with these new requirements.
Read More →
August 17, 2026

Massachusetts Introduces Extreme Temperature Protection Bill

The bill contains measures for temperatures below 60 degrees Fahrenheit, and above 90 degrees Fahrenheit.
Read More →
August 17, 2026

Colorado Study Evaluates Cannabis Reimbursement in Workers’ Comp

Among many aspects, the program involved a specialized medical cannabis physician who managed dosing, titration, and cannabinoid ratios.
Read More →
August 10, 2026

CMS Proposes 2027 Medicare Physician Fee Schedule Updates

Proposed changes would impact reimbursement for telehealth, evaluation and management, and more.
Read More →
August 10, 2026

Arizona Proposes $300 Topical Prescription Cap

The cap is for a 30-day supply. If actual acquisition cost exceeds $300, reimbursement would be limited to 120% of documented AAC.
Read More →
August 10, 2026

California Publishes Study on Cumulative Trauma Claims

CT claims nearly doubled from 9.1% of claims to 16.5% from 2018-2025, with these claims increasing across all regions, demographics, and tenures.
Read More →
August 10, 2026
1 2 3 4 … 61

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Presumption Expansions Throughout the Country

Several states continue to update presumptions for cancer, PTSD, and other conditions.
Read More

States Continue to Push for Psychedelic-Assisted Therapy Programs

Connecticut, Georgia, and Oklahoma enacted laws to enable certain programs, while a Louisiana bill awaits gubernatorial decisions.
Read More

What Is Marijuana’s Role in Pain Management?

The recent rescheduling of marijuana could be a boon to clinical research on pain management. What is marijuana’s potential role in treating pain?
Read More

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.
Read More

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.
Read More

Texas Approves Audit of Topical Analgesics

After soliciting stakeholder feedback on possible audit topics, the DWC prioritized a study of topical analgesics by the Medical Quality Review Panel.
Read More
1 2 3 4 … 52
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle